ATA260590A - Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen - Google Patents

Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen

Info

Publication number
ATA260590A
ATA260590A AT0260590A AT260590A ATA260590A AT A260590 A ATA260590 A AT A260590A AT 0260590 A AT0260590 A AT 0260590A AT 260590 A AT260590 A AT 260590A AT A260590 A ATA260590 A AT A260590A
Authority
AT
Austria
Prior art keywords
glycer
derivatives
production
same
compositions containing
Prior art date
Application number
AT0260590A
Other languages
English (en)
Other versions
AT398423B (de
Inventor
Pierre Braquet
Colette Broquet
Benedicte Vandamme
Paola Principe-Nicolas
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898929075A external-priority patent/GB8929075D0/en
Priority claimed from GB898929074A external-priority patent/GB8929074D0/en
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ATA260590A publication Critical patent/ATA260590A/de
Application granted granted Critical
Publication of AT398423B publication Critical patent/AT398423B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
AT0260590A 1989-12-22 1990-12-20 Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen AT398423B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929075A GB8929075D0 (en) 1989-12-22 1989-12-22 Glycerol derivatives
GB898929074A GB8929074D0 (en) 1989-12-22 1989-12-22 Glycerol derivatives

Publications (2)

Publication Number Publication Date
ATA260590A true ATA260590A (de) 1994-04-15
AT398423B AT398423B (de) 1994-12-27

Family

ID=26296423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0260590A AT398423B (de) 1989-12-22 1990-12-20 Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen

Country Status (26)

Country Link
US (1) US5116992A (de)
JP (1) JP2648730B2 (de)
KR (1) KR950012533B1 (de)
AR (1) AR247875A1 (de)
AT (1) AT398423B (de)
AU (1) AU635991B2 (de)
BE (1) BE1004091A3 (de)
CA (1) CA2032254C (de)
CH (1) CH681225A5 (de)
DE (1) DE4041449A1 (de)
DK (1) DK171021B1 (de)
ES (1) ES2027550A6 (de)
FI (1) FI906203L (de)
FR (2) FR2656221B1 (de)
GR (1) GR1000688B (de)
HK (1) HK117993A (de)
IE (1) IE65821B1 (de)
IT (1) IT1243413B (de)
LU (1) LU87860A1 (de)
NL (1) NL9002742A (de)
NO (1) NO178698C (de)
NZ (1) NZ236483A (de)
OA (1) OA09336A (de)
PT (1) PT96322B (de)
SE (1) SE501393C2 (de)
TN (1) TNSN90153A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928580D0 (en) * 1989-12-19 1990-02-21 Scras 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives
US5206027A (en) * 1990-09-13 1993-04-27 Fuji Photo Film Co., Ltd. Amphipathic compound and liposome comprising the same
DE69535758D1 (de) 1994-08-29 2008-07-03 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5707978A (en) * 1994-11-22 1998-01-13 Clarion Pharmaceuticals Inc. Heteroaryl-substituted deoxy glycero-phosphoethanolamines
US5703062A (en) * 1995-12-07 1997-12-30 Clarion Pharmaceuticals Inc. N-het-substituted glycerophosphoethanolamines
US5730157A (en) * 1995-12-07 1998-03-24 Clarion Pharmaceuticals Inc. Method for treating viral infection
US5665714A (en) * 1995-12-07 1997-09-09 Clarion Pharmaceuticals Inc. N-substituted glycerophosphoethanolamines
US5827836A (en) * 1996-11-15 1998-10-27 Clarion Pharmaceuticals Inc. Retinoid glycerol phospholipid conjugates
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
EP2574341B1 (de) 2004-03-29 2017-03-29 University Of South Florida Wirksame Behandlung von Tumoren und Krebs mit Triciribin-Phosphat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3323871A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue 1-o-alkyl-3-amino-propan-1,2-diol-2-o-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives

Also Published As

Publication number Publication date
PT96322B (pt) 1998-06-30
US5116992A (en) 1992-05-26
FR2656221B1 (fr) 1992-09-18
FR2656308A1 (fr) 1991-06-28
DK304090A (da) 1991-06-23
DK304090D0 (da) 1990-12-21
CA2032254A1 (en) 1991-06-23
NO178698C (no) 1996-05-15
CA2032254C (en) 1996-12-10
IT9022439A0 (it) 1990-12-19
SE501393C2 (sv) 1995-02-06
NZ236483A (en) 1993-02-25
FI906203A0 (fi) 1990-12-17
GR900100847A (en) 1992-05-12
FR2656221A1 (fr) 1991-06-28
NO905377D0 (no) 1990-12-12
OA09336A (fr) 1992-09-15
KR950012533B1 (ko) 1995-10-18
AU635991B2 (en) 1993-04-08
SE9003973D0 (sv) 1990-12-12
TNSN90153A1 (fr) 1991-03-05
AR247875A1 (es) 1995-04-28
IT1243413B (it) 1994-06-10
AU6837990A (en) 1991-07-11
CH681225A5 (de) 1993-02-15
HK117993A (en) 1993-11-12
BE1004091A3 (fr) 1992-09-22
NO178698B (no) 1996-02-05
AT398423B (de) 1994-12-27
IT9022439A1 (it) 1992-06-19
SE9003973L (sv) 1991-06-23
PT96322A (pt) 1991-09-30
FR2656308B1 (fr) 1994-04-01
JP2648730B2 (ja) 1997-09-03
DE4041449A1 (de) 1991-06-27
DK171021B1 (da) 1996-04-22
JPH0616605A (ja) 1994-01-25
GR1000688B (el) 1992-10-08
NL9002742A (nl) 1991-07-16
LU87860A1 (fr) 1991-05-07
IE904618A1 (en) 1991-07-17
KR910011760A (ko) 1991-08-07
ES2027550A6 (es) 1992-06-01
FI906203A7 (fi) 1991-06-23
FI906203L (fi) 1991-06-23
NO905377L (no) 1991-06-24
IE65821B1 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68907057D1 (de) Naehrstoffzusammensetzung und verfahren zu deren herstellung.
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
ATA256092A (de) Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69130221D1 (de) Oligosaccharidoxazolines, konjugate von oligosacchariden und verfahren zu ihrer herstellung
DE3782994D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE3862937D1 (de) 3-oxo-propannitril heteroarylderivate und verfahren zu deren herstellung.
ATA56790A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE194616T1 (de) Substituierte 4-phenyl-thiazole derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen die sie enthalten
DE3767789D1 (de) Substituierte aminodihydrooxazole, -thiazole und -imidazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATA95690A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3675714D1 (de) Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68910523D1 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
ATA328587A (de) Neue furanuronsaeure-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA86690A (de) 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA56690A (de) Sulfonylderivate der thieno-triazolo-diazepine, verfahren zu deren herstellung und sie enthaltendetherapeutische zusammensetzungen
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee